Endotoxin removal is one of the most persistent bottlenecks in bringing therapeutic bacteriophages to market. Produced by the outer membrane of Gram-negative bacteria, endotoxins (lipopolysaccharides, or LPS) can trigger severe immune reactions in patients if not reduced to ultra-low levels. For a Contract Development and Manufacturing Organization (CDMO), especially one producing phage therapies at GMP […]
Category: Bioengineering
Precision Bioengineering: Uniting Food, Pharma, and Gene Therapies
Biotechnology is at a crossroads. As the world grapples with feeding nearly 10 billion people, combating rising healthcare costs, and tackling genetic diseases at their root, three fields—alternative proteins, biologics, and cell & gene therapies—are rapidly maturing. What unites them is more than lofty ambition; it’s precision bioengineering, the art and science of designing, scaling, and […]